Nuveen Asset Management, LLC Ventyx Biosciences, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 168,420 shares of VTYX stock, worth $242,524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168,420
Previous 168,420
-0.0%
Holding current value
$242,524
Previous $367,000
0.27%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VTYX
# of Institutions
134Shares Held
55.2MCall Options Held
81.4KPut Options Held
148K-
Black Rock Inc. New York, NY4.77MShares$6.87 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.48MShares$6.45 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.27MShares$6.15 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY4.05MShares$5.83 Million3.31% of portfolio
-
Ubs Group Ag3.78MShares$5.45 Million0.0% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $81.4M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...